{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:35:05Z","timestamp":1792211705984,"version":"4.4.0"},"reference-count":98,"publisher":"S. Karger AG","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney Dis"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1159\/000487136","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T21:01:18Z","timestamp":1522875678000},"page":"65-73","source":"Crossref","is-referenced-by-count":31,"title":["The Genetic and Environmental Factors of Primary Membranous Nephropathy: An Overview from China"],"prefix":"10.1159","volume":"4","author":[{"given":"Xiao-dan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Ronco P, Debiec H: Pathophysiological advances in membranous nephropathy: time for a shift in patient\u2019s care. Lancet 2015; 385: 1983\u20131992.","DOI":"10.1016\/S0140-6736(15)60731-0"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Deegens JK, Wetzels JF: Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging 2007; 24: 717\u2013732.","DOI":"10.2165\/00002512-200724090-00002"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Fogo AB, Lusco MA, Najafian B, et al: AJKD atlas of renal pathology: membranous nephropathy. Nephrol Dial Transplant 2011; 26: 3425\u20133426.","DOI":"10.1093\/ndt\/gfr563"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, et al: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11\u201321.","DOI":"10.1056\/NEJMoa0810457"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al: Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014; 371: 2277\u20132287.","DOI":"10.1056\/NEJMoa1409354"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Debiec H, Guigonis V, Mougenot B, et al: Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053\u20132060.","DOI":"10.1056\/NEJMoa012895"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Debiec H, Lefeu F, Kemper MJ, et al: Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 2011; 364: 2101\u20132110.","DOI":"10.1056\/NEJMoa1013792"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Floege J, Amann K: Primary glomerulonephritides. Lancet 2016; 387: 2036\u20132048.","DOI":"10.1016\/S0140-6736(16)00272-5"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Hanko JB, Mullan RN, O\u2019Rourke DM, et al: The changing pattern of adult primary glomerular disease. Nephrol Dial Transplant 2009; 24: 3050\u20133054.","DOI":"10.1093\/ndt\/gfp254"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Braden GL, Mulhern JG, O\u2019Shea MH, et al: Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000; 35: 878\u2013883.","DOI":"10.1016\/S0272-6386(00)70258-7"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Stratta P, Segoloni GP, Canavese C, et al: Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis 1996; 27: 631\u2013639.","DOI":"10.1016\/S0272-6386(96)90096-7"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Woo KT, Chan CM, Chin YM, et al: Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract 2010; 116:c337\u2013c346.","DOI":"10.1159\/000319594"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Golay V, Trivedi M, Abraham A, et al: The spectrum of glomerular diseases in a single center: a clinicopathological correlation. Indian J Nephrol 2013; 23: 168\u2013175.","DOI":"10.4103\/0971-4065.111833"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Zhu P, Zhou FD, Wang SX, et al: Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: a 10-year renal biopsy study from a single Chinese nephrology center. Nephrology (Carlton) 2015; 20: 560\u2013566.","DOI":"10.1111\/nep.12542"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Tang LJ, Yao J, Kong XL, et al: Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: a cross-sectional study in China. Nephrology 2017; 22: 168\u2013173.","DOI":"10.1111\/nep.12739"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Pan XX, Xu J, Ren H, et al: Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China. Contrib Nephrol 2013; 181: 22\u201330.","DOI":"10.1159\/000348638"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Xu X, Wang G, Chen N, et al: Long-term exposure to air pollution and increased risk of membranous nephropathy in china. J Am Soc Nephrol 2016; 27: 3739\u20133746.","DOI":"10.1681\/ASN.2016010093"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Couser WG, Johnson RJ: The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int 2014; 86: 905\u2013914.","DOI":"10.1038\/ki.2014.49"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Couser WG, Salant DJ: In situ immune complex formation and glomerular injury. Kidney Int 1980; 17: 1\u201313.","DOI":"10.1038\/ki.1980.1"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Debiec H, Nauta J, Coulet F, et al: Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 2004; 364: 1252\u20131259.","DOI":"10.1016\/S0140-6736(04)17142-0"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Hoxha E, Thiele I, Zahner G, et al: Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 2014; 25: 1357\u20131366.","DOI":"10.1681\/ASN.2013040430"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Beck LH Jr: PLA2R and THSD7A: Disparate paths to the same disease? J Am Soc Nephrol 2017; 28: 2579\u20132589.","DOI":"10.1681\/ASN.2017020178"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Kao L, Lam V, Waldman M, et al: Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy. J Am Soc Nephrol 2015; 26: 291\u2013301.","DOI":"10.1681\/ASN.2013121315"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Fresquet M, Jowitt TA, Gummadova J, et al: Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol 2015; 26: 302\u2013313.","DOI":"10.1681\/ASN.2014050502"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Seitz-Polski B, Dolla G, Payre C, et al: Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy. J Am Soc Nephrol 2015; 27: 1517\u20131533.","DOI":"10.1681\/ASN.2014111061"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Du Y, Li J, He F, et al: The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis. PLoS One 2014; 9:e104936.","DOI":"10.1371\/journal.pone.0104936"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Hu SL, Wang D, Gou WJ, et al: Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis. J Nephrol 2014; 27: 111\u2013116.","DOI":"10.1007\/s40620-014-0042-7"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Dai HZ, Zhang HH, He YN: Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis. Sci Rep 2015; 5: 8803.","DOI":"10.1038\/srep08803"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Xie Q, Li Y, Xue J, et al: Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am J Nephrol 2015; 41: 345\u2013353.","DOI":"10.1159\/000431331"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Qin WS, Beck LH Jr, Zeng C, et al: Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1137\u20131143.","DOI":"10.1681\/ASN.2010090967"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Wang J, Cui Z, Lu J, et al: Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2017; 12: 1642\u20131651.","DOI":"10.2215\/CJN.01460217"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Pang L, Zhang AM, Li HX, et al: Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy. Medicine (Baltimore) 2017; 96:e7218.","DOI":"10.1097\/MD.0000000000007218"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Lin L, Wang WM, Pan XX, et al: Biomarkers to detect membranous nephropathy in Chinese patients. Oncotarget 2016; 7: 67868\u201367879.","DOI":"10.18632\/oncotarget.12014"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Kanigicherla D, Gummadova J, McKenzie EA, et al: Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 2013; 83: 940\u2013948.","DOI":"10.1038\/ki.2012.486"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Ruggenenti P, Debiec H, Ruggiero B, et al: Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol 2015; 26: 2545\u20132558.","DOI":"10.1681\/ASN.2014070640"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Hofstra JM, Beck LH Jr, Beck DM, et al: Anti-phospholipase A receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 1286\u20131291.","DOI":"10.2215\/CJN.07210810"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Bech AP, Hofstra JM, Brenchley PE, et al: Association of anti-PLA(2)R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2014; 9: 1386\u20131392.","DOI":"10.2215\/CJN.10471013"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Kattah A, Ayalon R, Beck LH Jr, et al: Anti-phospholipase A (2) receptor antibodies in recurrent membranous nephropathy. Am J Transplant 2015; 15: 1349\u20131359.","DOI":"10.1111\/ajt.13133"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Beck LH Jr, Fervenza FC, Beck DM, et al: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1543\u20131550.","DOI":"10.1681\/ASN.2010111125"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Hoxha E, Harendza S, Pinnschmidt HO, et al: Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody negative patients with membranous nephropathy. Nephrol Dial Transplant 2015; 30: 1862\u20131869.","DOI":"10.1093\/ndt\/gfv228"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Elshihabi I, Kaye CI, Brzowski A: Membranous nephropathy in two human leukocyte antigen-identical brothers. J Pediatr 1993; 123: 940\u2013942.","DOI":"10.1016\/S0022-3476(05)80391-9"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Sato K, Oguchi H, Hora K, et al: Idiopathic membranous nephropathy in two brothers. Nephron 1987; 46: 174\u2013178.","DOI":"10.1159\/000184336"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Vangelista A, Tazzari R, Bonomini V: Idiopathic membranous nephropathy in 2 twin brothers. Nephron 1988; 50: 79\u201380.","DOI":"10.1159\/000185130"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Vivarelli M, Emma F, Pell\u00e9 T, et al: Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies. Kidney Int 2015; 87: 602\u2013609.","DOI":"10.1038\/ki.2014.381"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Meroni M, Volpi A, Usberti M, et al: Two brothers with idiopathic membranous nephropathy and familial sensorineural deafness. Am J Kidney Dis 1990; 15: 269\u2013272.","DOI":"10.1016\/S0272-6386(12)80773-6"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Mezzano S, Rojas G, Ardiles L, et al: Idiopathic membranous nephropathy, associated with HLA-DRw3 and not related to monocyte-phagocyte system Fc receptor dysfunction, in father and son. Nephron 1991; 58: 320\u2013324.","DOI":"10.1159\/000186444"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Izzi C, Sanna-Cherchi S, Prati E, et al: Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int 2006; 69: 1033\u20131040.","DOI":"10.1007\/s11255-017-1543-9"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Guella A, Akhtar M, Ronco P: Idiopathic membranous nephropathy in identical twins. Am J Kidney Dis 1997; 29: 115\u2013118.","DOI":"10.1016\/S0272-6386(97)90017-2"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Stanescu HC, Arcos-Burgos M, Medlar A, et al: Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364: 616\u2013626.","DOI":"10.1056\/NEJMoa1009742"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Bullich G, Ballar\u00edn J, Oliver A, et al: HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2014; 9: 335\u2013343.","DOI":"10.2215\/CJN.05310513"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Lv JC, Hou WY, Zhou XJ, et al: Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol 2013; 24: 1323\u20131329.","DOI":"10.1681\/ASN.2012080771"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Ramachandran R, Kumar V, Kumar A, et al: PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians. Nephrol Dial Transplant 2016; 31: 1486\u20131493.","DOI":"10.1093\/ndt\/gfv399"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Kim S, Chin HJ, Na KY, et al: Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy. Nephron Clin Pract 2011; 117:c253\u2013c258.","DOI":"10.1159\/000320194"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Liu YH, Chen CH, Chen SY, et al: Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan. J Biomed Sci 2010; 17: 81.","DOI":"10.1186\/1423-0127-17-81"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Coenen MJ, Hofstra JM, Debiec H, et al: Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol 2013; 24: 677\u2013683.","DOI":"10.1681\/ASN.2012070730"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Gupta S, K\u00f6ttgen A, Hoxha E, et al: Genetics of membranous nephropathy. Nephrol Dial Transplant 2017, DOI: 10.1093\/ndt\/gfx296.","DOI":"10.1093\/ndt\/gfx296"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Saeed M, Beggs ML, Walker PD, et al: PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes. Genes Immun 2014; 15: 556\u2013561.","DOI":"10.1038\/gene.2014.50"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Larsen CP, Beggs ML, Walker PD, et al: Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy. Am J Kidney Dis 2014; 64: 161\u2013163.","DOI":"10.1053\/j.ajkd.2014.02.024"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Meyer D, C Aguiar VR, Bitarello BD, et al: A genomic perspective on HLA evolution. Immunogenetics 2018; 70: 5\u201327.","DOI":"10.1007\/s00251-017-1017-3"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Vaughan RW, Tighe MR, Boki K, et al: An analysis of HLA class II gene polymorphism in British and Greek idiopathic membranous nephropathy patients. Eur J Immunogenet 1995; 22: 179\u2013186.","DOI":"10.1111\/j.1744-313X.1995.tb00228.x"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Fernando MM, Stevens CR, Sabeti PC, et al: Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007; 3:e192.","DOI":"10.1371\/journal.pgen.0030192"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Fernando MM, Stevens CR, Walsh EC, et al: Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008; 4:e1000024.","DOI":"10.1371\/journal.pgen.1000024"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Vaughan RW, Demaine G, Welsh KI: A DQAl allele is strongly associated with idiopathic membranous nephropathy. Tissue Antigens 1989; 34: 261\u2013269.","DOI":"10.1111\/j.1399-0039.1989.tb01741.x"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Chevrier D, Giral M, Perrichot R, et al: Idiopathic and secondary membranous nephropathy and polymorphism at TAPl and HLA-DMA loci. Tissue Antigens 1997; 50: 164\u2013169.","DOI":"10.1111\/j.1399-0039.1997.tb02855.x"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Hiki Y, Kobayashi Y, Itoh I, et al: Strong association of HLA-DR2 and MTI with idiopathic membranous nephropathy in Japan. Kidney Int 1984; 25: 953\u2013957.","DOI":"10.1016\/j.ijcard.2016.08.296"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Ogahara S, Naito S, Abe K, et al: Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. Kidney Int 1992; 41: 175\u2013182.","DOI":"10.1038\/ki.1992.24"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Thiri M, Honda K, Kashiwase K, et al: High-density association mapping and interaction analysis of PLA2R1 and HLA regions with idiopathic membranous nephropathy in Japanese. Sci Rep 2016; 6: 38189.","DOI":"10.1038\/srep38189"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Mladkova N, Kiryluk K: Genetic complexities of the HLA region and idiopathic membranous nephropathy. J Am Soc Nephrol 2017; 28: 1331\u20131334.","DOI":"10.1681\/ASN.2017030283"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Cui Z, Xie LJ, Chen FJ, et al: MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy. J Am Soc Nephrol 2017; 28: 1651\u20131664.","DOI":"10.1681\/ASN.2016020114"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Le WB, Shi JS, Zhang T, et al: HLA-DRB1 1501 and HLA-DRB3 0202 in PLA2R-related membranous nephropathy. J Am Soc Nephrol 2017; 28: 1642\u20131650.","DOI":"10.1681\/ASN.2016060644"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"van Donkelaar A, Martin RV, Brauer M, et al: Use of satellite observations for long-term exposure assessment of global concentrations of fine particulate matter. Environ Health Perspect 2015; 123: 135\u2013143.","DOI":"10.1289\/ehp.1408646"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Miller KA, Siscovick DS, Sheppard L, et al: Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007; 356: 447\u2013458.","DOI":"10.1056\/NEJMoa054409"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Pfau JC, Brown JM, Holian A: Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004; 195: 167\u2013176.","DOI":"10.1016\/j.tox.2003.09.011"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Brown JM, Pfau JC, Holian A: Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol 2004; 16: 133\u2013139.","DOI":"10.1080\/08958370490270936"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Ritz SA: Air pollution as a potential contributor to the \u201cepidemic\u201d of autoimmune disease. Med Hypotheses 2010; 74: 110\u2013117.","DOI":"10.1016\/j.mehy.2009.07.033"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Panasevich S, Leander K, Rosenlund M, et al: Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med 2009; 66: 747\u2013753.","DOI":"10.1136\/oem.2008.043471"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Thibaudin D, Thibaudin L, Berthoux P, et al: TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset\/occurrence of idiopathic membranous nephropathy. Kidney Int 2007; 71: 431\u2013437.","DOI":"10.1038\/sj.ki.5002054"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Bantis C, Heering PJ, Aker S, et al: Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am J Nephrol 2006; 26: 12\u201315.","DOI":"10.1159\/000090706"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Chen CH, Shu KH, Wen MC, et al: Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy. Nephrol Dial Transplant 2008; 23: 3166\u20133173.","DOI":"10.1093\/ndt\/gfn258"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Luo Y, Wang C, Tu H: Impact of the 4G\/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome. Mol Med Rep 2014; 9: 894\u2013898.","DOI":"10.3892\/mmr.2014.1903"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Chen SY, Chen CH, Huang YC, et al: Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population. Ren Fail 2010; 32: 1172\u20131176.","DOI":"10.3109\/0886022X.2010.516857"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Kazi JI, Mubarak M, Ahmed E, et al: Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan. Clin Exp Nephrol 2009; 13: 38\u201343.","DOI":"10.1007\/s10157-008-0075-0"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Rychl\u00edk I, Jancov\u00e1 E, Tesa\u0159 V, et al: The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994\u20132000. Nephrol Dial Transplant 2004; 19: 3040\u20133049.","DOI":"10.1093\/ndt\/gfh521"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Das U, Dakshinamurty KV, Prayaga A: Pattern of biopsy-proven renal disease in a single center of south India: 19 years experience. Indian J Nephrol 2011; 21: 250\u2013257.","DOI":"10.4103\/0971-4065.85482"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Beniwal P, Pursnani L, Sharma S, et al: A clinicopathologic study of glomerular disease: a single-center, five-year retrospective study from Northwest India. Saudi J Kidney Dis Transpl 2016; 27: 997\u20131005.","DOI":"10.4103\/1319-2442.190876"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Simon P, Ramee MP, Boulahrouz R, et al: Epidemiologic data of primary glomerular diseases in western France. Kidney Int 2004; 66: 905\u2013908.","DOI":"10.1111\/j.1523-1755.2004.00834.x"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Simon P, Ram\u00e9e MP, Autuly V, et al: Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int 1994; 46: 1192\u20131198.","DOI":"10.1038\/ki.1994.384"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Polito MG, de Moura LA, Kirsztajn GM: An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9,617 native kidney biopsies. Nephrol Dial Transplant 2010; 25: 490\u2013496.","DOI":"10.1093\/ndt\/gfp355"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Swaminathan S, Leung N, Lager DJ, et al: Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol 2006; 1: 483\u2013487.","DOI":"10.2215\/CJN.00710805"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Sugiyama H, Yokoyama H, Sato H, et al: Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 2011; 15: 493\u2013503.","DOI":"10.1007\/s10157-011-0430-4"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Chang JH, Kim DK, Kim HW, et al: Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant 2009; 24: 2406\u20132410.","DOI":"10.1093\/ndt\/gfp091"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Choi IJ, Jeong HJ, Han DS, et al: An analysis of 4,514 cases of renal biopsy in Korea. Yonsei Med J 2001; 42: 247\u2013254.","DOI":"10.3349\/ymj.2001.42.2.247"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Yang YR, Chen YM, Chen SY, et al: Associations between long-term particulate matter exposure and adult renal function in the Taipei metropolis. Environ Health Perspect 2017; 125: 602\u2013607.","DOI":"10.1289\/EHP302"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Moriyama T, Kaneko T, Fujii M, et al: High prevalence of <italic>Helicobacter pylori<\/italic> infection in Japanese patients with membranous nephropathy. Aliment Pharmacol Ther 2007; 24: 189\u2013193.","DOI":"10.1111\/j.1365-2036.2006.00044.x"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Kronbichler A, Kerschbaum J, Mayer G: The influence and role of microbial factors in autoimmune kidney diseases: a systematic review. J Immunol Res 2015; 2015: 858027.","DOI":"10.1155\/2015\/858027"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Li Q, Lin X, Wu Z, et al: Immuno-histochemistry analysis of <italic>Helicobacter pylori<\/italic> antigen in renal biopsy specimens from patients with glomerulonephritis. Saudi J Kidney Dis Transpl 2013; 24: 751\u2013758.","DOI":"10.4103\/1319-2442.113871"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Sugimoto T, Furukawa T, Maeda T, et al: Marked reduction of proteinuria after eradication of gastric <italic>Helicobacter pylori<\/italic> infection in a patient with membranous nephropathy: coincidental or associated? Intern Med 2007; 46: 1483\u20131484.","DOI":"10.2169\/internalmedicine.46.0200"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Gradden CW, Pai P, Hindell P, et al: Membranous nephropathy, hydrocarbon exposure and genetic variants of hydrocarbon detoxification. QJM 2001; 94: 79\u201387.","DOI":"10.1093\/qjmed\/94.2.79"}],"container-title":["Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/487136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/487136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:40:30Z","timestamp":1745426430000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000487136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":98,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6,12]]},"published-print":{"date-parts":[[2018,6,19]]}},"URL":"https:\/\/doi.org\/10.1159\/000487136","archive":["Portico"],"relation":{},"ISSN":["2296-9381","2296-9357"],"issn-type":[{"value":"2296-9381","type":"print"},{"value":"2296-9357","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}